AusCann is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally. AusCann focuses on transforming the way medical cannabis is supplied by making standardised dose-controlled cannabinoid-based pharmaceutical products and clinical evidence accessible to patients, physicians and healthcare providers. AusCann provides healthcare providers with the opportunity to treat their patients with a reliable and stable cannabinoid-based pharmaceutical product, monitor treatment results and adjust treatment algorithms using a portfolio of products and formulations.
View Top Employees from AusCann Group Holdings Pty Ltd| Website | http://www.auscann.com.au |
| Ticker | ASX:AC8 |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2013 |
| Address | 35 Havelock Street, Level 4, West Perth, Western Australia 6005, AU |
| Phone | +61 8 6305 0705 |
| Fax | +61 8 6255 2031 |
| Industry | Pharmaceuticals, Alternative Medicine, Healthcare, Health Care, Cannabis, Community and Lifestyle, Food and Beverage |
| SIC | SIC Code 515 Companies, SIC Code 51 Companies |
| NAICS | NAICS Code 453 Companies, NAICS Code 45 Companies |
Looking for a particular AusCann Group Holdings Pty Ltd employee's phone or email?
AusCann Group Holdings Pty Ltd Questions
The AusCann Group Holdings Pty Ltd annual revenue was $5 million in 2024.
AusCann Group Holdings Pty Ltd is based in West Perth, Western Australia.
The NAICS codes for AusCann Group Holdings Pty Ltd are [453, 45].
The SIC codes for AusCann Group Holdings Pty Ltd are [515, 51].
